pharma-and-clinical-pharmacy-congress-2016_tracks

17 / 21

Notes:
Page 45
Pharma & Clinical Pharmacy Congress 2016
November 07-09, 2016
Volume 5 Issue 4(Suppl) Clin Pharmacol Biopharm
ISSN: 2167-065X CPB, an open access journal
conferenceseries .com
November 07-09, 2016 Las Vegas, Nevada, USA
4th International
Pharma & Clinical Pharmacy Congress
Mayuri Gupta Pathak, Clin Pharmacol Biopharm 2016, 5:4(Suppl)
A comparative study on efficacy of polymyxin B, neomycin and polymyxin B, neomycin,
hydrocortisone in the treatment of Otitis Externa
Mayuri Gupta Pathak
Patan Academic of Health Science, India
Introduction: Acute otitis externa is a common condition involving inflammation of the ear canal. The acute form is caused
primarily by bacterial infection, with Pseudomonas aeruginosa and Staphylococcus aureus the most common pathogens.
Acute otitis externa presents with the rapid onset of ear canal inflammation, resulting in otalgia, itching, canal edema, canal
erythema, and otorrhea and often occurs following swimming or minor trauma from inappropriate cleaning. Tenderness with
movement of the tragus or pinna is a classic finding. Neomycin/polymyxin B/hydrocortisone preparations are a reasonable
first-line therapy when the tympanic membrane is intact. Oral antibiotics are reserved for cases in which the infection has
spread beyond the ear canal or in patients at risk of a rapidly progressing infection.
Aim: To compare the efficacy of polymyxin B, Neomycin and Polymyxin B, Neomycin, Hydrocortisone in the treatment of
Otitis externa.
Methodology: This study was carried out in the Department of ENT, Nepal Medical College Teaching Hospital (NMCTH),
Nepal from August 2012 to May 2014. This, prospective randomized study included patients with otitis externa. Patients of all
age groups and both gender were included in this study. Patients were randomized into two groups; Group A patients, who
received Polymyxin B, Neomycin and Group B patients who received Polymyxin B, Neomycin, Hydrocortisone. Pack soaked
either with polymyxin B neomycin/ hydrocortisone and applied for 48 hours. If not recover again applied for next 48 hours.
Biography
Mayuri Gupta Pathak obtained MD in Clinical Pharmacology from Nepal Medical College Teaching Hospital (NMCTH), Kathmandu, Nepal in 2015. She obtained
MBBS from Kathmandu Medical College Teaching Hospital (KMCTH), Kathmandu, NEPAL in 2006. She is currently working as Lecturer at Patan Academic of
Health Science (PAHS), Kathmandu Nepal. She worked as a tutor in Clinical Pharmacology before starting MD for 3 months in NMCTH. Her trainings include
Neonatal advanced life support in KMCTH, Interdepartmental clinical meeting on “Diabetics and Anesthesia” in KMCTH and advanced cardiac life support in
Anesthesia in NMCTH.